NCT06016738 2026-03-13
OPERA-01
Olema Pharmaceuticals, Inc.
Phase 3 Recruiting
Olema Pharmaceuticals, Inc.
Merck Sharp & Dohme LLC
Eli Lilly and Company
Eli Lilly and Company
Novartis
SAPU NANO (US) LLC
Merck Sharp & Dohme LLC
Jiangsu Simcere Pharmaceutical Co., Ltd.
AstraZeneca